WHO ICTRP trial
Anticoagulation for pyrrolidine alkaloid plants induced hepatic sinusoidal…
ChiCTR-IPR-17010784 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-IPR-17010784 |
|---|---|
| Public title | Anticoagulation for pyrrolidine alkaloid plants induced hepatic sinusoidal obstruction syndrome (PA - HSOS): a prospective multicenter randomized controlled study. |
| Scientific title | Anticoagulation for PA-HSOS: a multicenter RCT |
| Primary sponsor | Drum Tower Hospital affiliated to Nanjing University Medicine School |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | hepatic sinusoidal obstruction syndrome |
| Interventions | 2:conventional symptomatic treatment;2: low molecular heparin, warfarin |
| Registration date | Mar 5, 2017 |
| Target size | 2:113;2:113 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: